XOMA Corp (NASDAQ:XOMA)

19.48
Delayed Data
As of Aug 14
 +0.88 / +4.73%
Today’s Change
14.14
Today|||52-Week Range
28.85
-28.64%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$181.0M

Company Description

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

Contact Information

XOMA Corp.
2200 Powell Street
Emeryville California 94608
P:(510) 204-7200
Investor Relations:

Employees

Shareholders

Other institutional48.61%
Individual stakeholders37.40%
Mutual fund holders10.46%

Top Executives

James R. NealChief Executive Officer & Director
Thomas BurnsChief Financial Officer & Senior VP-Finance